(USD) | Mar 2024 | Q/Q |
---|---|---|
Revenue | 3.1B | -1% |
Gross Profit | 2.7B | - |
Cost Of Revenue | 487MM | -1% |
Operating Income | 231MM | -30% |
Operating Expenses | 2.4B | - |
Net Income | -41MM | -187% |
Compensation | 1.4B | -0% |
Amortization | 115MM | -5% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Q1 2024 Community Health Systems Inc Earnings Call
Community Health's (CYH) first-quarter results benefit from improved occupancy and reimbursement rates. However, declining admissions partially offset the positives.
The health system made progress on controlling expenses by cutting contract labor costs and insourcing physicians, but costs still dragged on earnings.
Although the revenue and EPS for Community Health Systems (CYH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Insights into CYH's Financial Performance and Strategic Improvements
Community Health Systems (CYH) delivered earnings and revenue surprises of 26.32% and 1.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FRANKLIN, Tenn., April 24, 2024--Community Health Systems, Inc. (NYSE: CYH) (the "Company") today announced financial and operating results for the three months ended March 31, 2024.
Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
CEO Tim Hingtgen told investors in February that divestitures could yield more than $1 billion for the hospital operator.
The health systems argued in a court filing that regulators’ allegations are based on a “distorted and artificially narrow view” of the healthcare market in the Charlotte area.